NexPoint Participates in Series C Financing for Apnimed, a Clinical-stage Pharmaceutical Company Focused on Treating Sleep Disorders
CAMBRIDGE, Mass. May 4, 2022 – Apnimed, a clinical-stage pharmaceutical company focused on developing oral pharmacologic treatments to address obstructive sleep apnea (OSA) and related disorders, announced today that it has raised $62.5 million of committed capital in a Series C financing. New investor, Sectoral Asset Management, led the round. Also participating were new investors […]
Dallas-Fort Worth Named a Top Market for Emerging Life Science
2021 brought a record-setting level of investment in life sciences with nearly $150 Billion of private and public funding, according to Cushman Wakefield and the National Institute of Health (NIH). 2021 brought a record-setting level of investment in life sciences with nearly $150 Billion of private and public funding, according to Cushman Wakefield and the […]
How COVID-19 is Transforming Life Sciences Real Estate
Although COVID-19 has certainly disrupted the real estate world, it has also, paradoxically, generated a novel opportunity for the industry and its evolution. The explosive growth of the global life sciences sector and the real property needs it entails have captured the attention of commercial real estate investors of all stripes. According to CBRE’s US […]
